ENDOTHELIAL PROTECTION IN THE REHABILITATION OF PATIENTS WITH POSTSTROKE APHASIA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

An open randomized controlled study was conducted to comprehensively examine the dynamics of recovery of speech functions and to simultaneously estimate the level of markers for endothelial dysfunction in patients with prior ischemic stroke when naftidrofuryl (Duzofarm) is incorporated into the treatment regimen.

Full Text

Restricted Access

About the authors

V. Shishkova

Center for Speech Pathology and Neurorehabilitation

Email: veronika-1306@mail.ru
Candidate of Medical Sciences Moscow

A. Remennlk

Center for Speech Pathology and Neurorehabilitation

Moscow

L. Zotova

Center for Speech Pathology and Neurorehabilitation

Moscow

References

  1. Redon J., Olsen М., Cooper R. et al. Stroke mortality trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure // Eur. Heart J. - 2011; 32: 1424-31.
  2. Гусев Е.И., Скворцова В.И., Стаховская Л.В. Проблема инсульта в Российской Федерации: время активных совместных действий // Журн. неврол. и психиат. - 2007; 8: 4-10.
  3. Libby Р., Ridker P., Hansson G. Information in atherosclerosis from pathophysiology to practice // J. Am. Coll. Cardiol. - 2009; 54: 2129-38.
  4. Muller W. Mechanisms of transendothelial migration of leukocytes // Circ. Res. - 2009; 105 (3): 223-30.
  5. Zarbock A., Ley K. Neutrophil adhesion and activation under flow // Microcirculation. - 2009; 16 (1): 31^42.
  6. Luscher T., Noll G. The endothelium as a regulator of vascular tone and growth. The endothelium in cardiovascular disease: pathophysiology, clinical presentation, and pharmacotherapy / Berlin, 1995; p. 1-24.
  7. Poncin-Lafitte M., Grosdemouge C., Roy-Billon C. et al. Effects of naftidrofuryl on cerebral hemodynamics, metabolism and function after a retracted ischaemia // Arch. Int. Pharmacodyn. Ther. -1982; 260 (2): 218-29.
  8. Oudart N. Naftidrofuryl inhibits contractions to serotoninin intact and de-endothelialized cerebral arteries in vitro // J. Cardiovasc. Pharmacol. - 1990; 16 (Suppl. 3): 45-8.
  9. Wiemsperger N. Serotonin, 5HT receptors and brain circulation // J. Cardiovasc. Pharmacol. - 1990; 16 (Suppl. 3): 20-4. SB ВРАЧ 3 2018
  10. Lagrue G., Questel R. Indirect evaluation of blood oximetry by digitized conjunctival capillarography: effects of naftidrofuryl // J. Cardiovasc. Pharmacol. -1990; 16 (Suppl. 3): 67-71.
  11. Zander J., Aarhus L, Katusic Z. et al. Effects of naftidrofuryl on adrenergic nerves, endothelium and smooth muscle inisolated canine blood vessels // J. Pharmacol. Exp. Ther. - 1986; 239 (3): 760-7.
  12. Lepetit J., Dumond D., Gros J. Contrôle de l'activité du naftidrofuryl a la phase aigue des AVC par l'echopulsographietranscerebrale // Psychol. Med. - 1992; 24: 975-82.
  13. Kirsten R., Erdeg B., Moxter D. et al. Platelet aggregation after naftidrofuryl application in vitro and ex vivo H Int. J. Clin. Pharmacol. Ther. - 1995; 33 (2): 81-4.
  14. Herrmann K., Grosse-Heitmeyer A., Kreuzer H. Antithrombotic efficacy and its time course after application of naftidrofuryl in vivo // Arch. Int. Pharmacodyn. Ther.-1986; 284 (1): 145-54.
  15. Takeo S., Tanonaka R., Miyake K. et al. Naftidrofuryl oxalate improves impaired brain glucose metabolism after induced cerebral metabolism in rats // J. Pharmacol. Exp. Ther. - 1991; 257 (1): 404-10.
  16. Wiernsperger N. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular disease // J. Cardiovasc. Pharmacol. -1994; 23 (Suppl. 3): 37-43.
  17. Taguchi T., Takagi N., Miyake K. et al. Effects of naftidrofuryl oxalate on microsphereinduced changes in acetylcholine and amino acid content of rat brain regions // Exp. Brain Res. - 1994; 99 (1): 7-16.
  18. Louis J. Effect of naftidrofuryl on metabolism and survival of cultured neurons // Neurochem. Res.-1989; 14 (12): 1195-201.
  19. Скворцова В.И. Принципы ранней реабилитации больных с инсультом // Журн. неврол. и психиат. (Прил.: «Инсульт»), - 2002; 7: 28-33.
  20. Burns М. Application of Neuroscience to Technology in Stroke Rehabilitation // Top Stroke Rehabil. - 2008; 15: 570-9.
  21. Лукъянюк E.B., Шкловский B.M., Малюкова Н.Г. Опыт применения акатиноламемантина в резидуальном периоде инсульта // Журн. неврол. и психиат. (Прил.: «Инсульт»), - 2010; 12: 28-33.
  22. Шишкова В.Н, Зотова Л.И., Кан Н.В. и др. Оценка эффективности нафтидрофурила в составе ранней комплексной реабилитации у пациентов с постинсультной афазией // Врач. - 2017; 7: 47-50.
  23. Шишкова В.Н., Шкловский В.М., Ременник А.Ю. и др. Новые возможности оценки нейрореабилитационного потенциала у пациентов с постинсультной афазией // Мед. алфавит. - 2016; 1: 25-9.
  24. Adhoute G., Barcourt F., Barrai M. et al. Naftidrofuryl in chronic arterial disease: results of a sixmonth controlled multicenter study using Naftidrofuril tablets 200 mg // Angiology. - 1994; 35: 701-8.
  25. Lu D., Song H., Hao Z. etal. Naftidrofuryl for dementia (Review) // Cochrane Database Syst. Rev. - 2011; 12: CD002955. doi: 10.1002/14651858.CD002955.pub4.
  26. de Backer T., Vander Stichele R., Lehert P. et al. Naftidrofuryl for intermittent claudication // Cochrane Database Syst. Rev. - 2012; 12: CD001368.
  27. Золотовская И.А., Давыдкин И.Л. Возможности фармакологической коррекции структурно-функциональных изменений в условиях эндотелиальной дисфункции у коморбидных пациентов, перенесших инсульт // Клиницист. - 2016; 2: 32-42.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Russkiy Vrach Publishing House